advert
Angel News

Back to Homepage

2nd November 2018 - 0 comments

Shoosmiths advises Octopus Investments on clinical trial software deal

Shoosmiths has advised the intermediate capital team of Octopus Investments on its latest growth capital investment, into leading global clinical trial solutions provider Triumph Research Intelligence (TRI).

...

Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:

Name:

Email:

Comment:

Enter the characters in the image shown:



Back to Homepage